Index Note: Page numbers of article titles are in boldface type. A Ablation, of prostate, holmium laser, 485 495 African prune tree (Pygeum africanum), 454 455 Alfuzosin, 445 446 Alpha-adrenergic agonists, for BPH, 444 447 adverse effects, 446 447 second-generation, 445 446 third-generation, 446 Anticholinergics, for BPH, 452 453 B Benign prostatic hyperplasia (BPH), 403 569 bladder diverticula, 511 525 electroresection and open surgery, 461 470 laparoscopic and robotic simple prostatectomy, 467 468 open simple prostatectomy, 466 467 transurethral resection of prostate, 461 466 established medical therapy for, 443 459 alpha-adrenergic agonists, 444 447 anticholinergics, 452 453 combination therapy, 449 452 hormonal therapy, 447 449 phytotherapeutics, 453 455 etiology, epidemiology, and natural history of LUTS and, 403 415 association of BPH and prostate cancer, 405 effect of unrelieved outlet obstruction on detrusor function, 410 epidemiology of prostatic enlargement, 406 etiology of prostate enlargement, 403 405 incidence of urinary retention in aging men, 406 relationship between BPH and LUTS, 407 laser-based treatments, 471 483, 485 495 role of invasive urodynamic testing in, 431 441 Urol Clin N Am 36 (2009) 571 575 doi:10.1016/s0094-0143(09)00089-5 0094-0143/09/$ see front matter ª 2009 Elsevier Inc. All rights reserved. role of, 435 symptoms, symptom scores, and outcome measures, 417 429 Bladder compliance, decreased, after diverticulectomy, 523 case study, 567 568 Bladder diverticula, 511 525 case studies, 559 564 observation, 515 516 surgery of bladder outlet, 516 517 surgery of the diverticulum, 517 522 Bladder recovery, after laser enucleation of prostate, 488 Bladder, overactive. See Overactive bladder. Botulinum toxin, intraprostate injection of, for LUTS and BPH, 503 504 BPH. See Benign prostatic hyperplasia. C Case studies, decompensated large capacity bladder, 564 567 large bladder diverticulum, 560 564 overactive bladder with LUTS, 539 552 progression to renal failure while on medical treatment for LUTS, 552 555 urologic.theclinics.com
572 Index Case (continued) prostatic obstruction and medium-sized bladder diverticulum, 559 560 urinary retention in man with low bladder compliance, 567 568 young man presenting with renal failure, 555 559 Chronic pelvic pain syndrome, prostatitis and, 528 531 Combination therapy, for BPH, 449 452 Compliance, bladder, decreased, after diverticulectomy, 523 empiric treatment of urinary retention in man with low, 567 568 Cystitis, interstitial, Cystometry, filling, in evaluation of BPH and LUTS, 434 435 Cystoscopy, in evaluation of BPH and LUTS, 435 436 D Detrusor function, impaired contractility after diverticulectomy, 522 523 unrelieved outlet obstruction on, 410 Diverticula. See Bladder diverticula. Doxepin, 445 446 Dutasteride, 448 E Electroresection. See Surgery. Enucleation, of prostate, holmium laser, 485 495 Epidemiology, incidence of LUTS and urinary retention in aging men, 406 of prostatic enlargement, 406 relationship between LUTS and BPH, 407 Etiology, association of BPH and prostate cancer, 405 of lower urinary tract dysfunction, 405 406 of prostatic enlargement, 403 405 Extravesical excision, of bladder diverticulum, 522 F Filling cystometry, in evaluation of BPH and LUTS, 434 435 Finasteride, 447 448 Food supplements. See Phytotherapeutics. Fulguration, transurethral, of bladder diverticulum, 519, 522 G Genitourinary pain syndromes, and LUTS, 527 536 GreenLight laser, vaporization of prostate with, 471 483 H Holmium laser, applications in the prostate, 485 495 bladder recovery, 488 complications, 490 hemostasis, 486 instruments and settings, 486 487 learning curve, 492 outcomes of laser enucleation compared with open prostatectomy, 493 495 outcomes of laser enucleation compared with TURP, 491 493 physics of, 485 486 postoperative care, 488 surgical techniques, 487 490 ablation of prostate, 488 enucleation of prostate, 487 morcellation, 487 488 Hormonal therapy, for BPH, 447 449 adverse effects, 448 dutasteride, 448 finasteride, 447 448 prostate cancer and, 448 446 Hyperplasia, prostatic. See Benign prostatic Hypoxis rooperi, 455 I Injection therapy, for LUTS and BPH, 502 503 botulinum toxin intraprostate injection, 503 504 Interstitial cystitis, Intravesical excision, of bladder diverticulum, 522 Invasive tests. See Urodynamic testing. K KTP/LBO laser, vaporization of prostate with, 471 483 L Laparoscopy, in bladder diverticulectomy, 522 Laparosocpic prostatectomy, simple, 467 468 Laser-based treatment, of prostate in BPH, 471 483, 485 495
Index 573 Learning curve, with holmium laser ablation or enucleation of prostate vs. TURP, 492 Lithium triborate (LBO) laser, vaporization of prostate in BPH, 471 483 Lower urinary tract symptoms (LUTS), 497 569 bladder diverticula, 511 525 bladder diverticula, impaired detrusor contractility, and low bladder compliance, 511 525 case studies of patients with, 537 569 causes of, 538 539 etiology, epidemiology, and natural history of, 403 415 association of BPH and prostate cancer, 405 effect of unrelieved outlet obstruction on detrusor function, 410 epidemiology of prostatic enlargement, 406 etiology of prostate enlargement, 403 405 incidence of urinary retention in aging men, 406 relationship between BPH and LUTS, 407 genitourinary pain syndromes, 527 536 minimally invasive therapy for, 497 509 botulinum toxin, 503 504 injection therapy, 502 503 transurethral microwave thermotherapy (TUMT), 498 500 transurethral needle aspiration (TUNA) of prostate, 500 502 urethral stent, 504 505 minimally invasive therapy of, 497 509 role of invasive urodynamic testing in, 431 441 role of, 435 symptoms, symptom scores, and outcome measures, 417 429 LUTS. See Lower urinary tract symptoms. M Malignancy, concern for, with bladder diverticula, Medical therapy, established, for BPH, 443 459 alpha-adrenergic agonists, 444 447 adverse effects, 446 447 second-generation, 445 446 third-generation, 446 anticholinergics, 452 453 combination therapy, 449 452 hormonal therapy, 447 449 adverse effects, 448 dutasteride, 448 finasteride, 447 448 prostate cancer and, 448 449 phytotherapeutics, 453 455 African prune tree (Pygeum africanum), 454 455 other extracts, 455 saw palmetto (Serenoa repens), 454 South African star grass (Hypoxis rooperi), 455 Minimally invasive therapy, laser procedures for BPH, 471 483, 485 495 of LUTS and BPH, 497 509 botulinum toxin, 503 504 injection therapy, 502 503 transurethral microwave thermotherapy (TUMT), 498 500 transurethral needle aspiration (TUNA) of prostate, 500 502 urethral stent, 504 505 Morcellation, in laser enucleation of prostate, 487 488 N Natural history, effect of unrelieved outlet obstruction on detrusor function, 410 of LUTS, 410
574 Index Natural (continued) Neoplasms, concern for, with bladder diverticula, O Obstruction, relationship between LUTS and, unrelieved outlet, effect on detrusor function, 410 Open prostatectomy, simple, 466 467 Outcome measures, for LUTS and BPH, 417 429 Outcomes, of holmium laser enucleation of prostate, compared with open prostatectomy, 493 495 compared with TURP, 491 493 Overactive bladder, case studies, 539 552 P Pain syndromes, genitourinary, and LUTS, 527 536 Painful bladder syndrome, Pelvic floor pain syndrome, 533 Pelvic pain, prostatitis and chronic pelvic pain syndrome, 528 531 Physics, laser, 485 486 Phytotherapeutics, for BPH, 453 455 African prune tree (Pygeum africanum), 454 455 other extracts, 455 saw palmetto (Serenoa repens), 454 South African star grass (Hypoxis rooperi), 455 Plants. See Phytotherapeutics. Potassium-titanyl-phosphate (KTP) laser, vaporization of prostate in BPH, 471 483 Pressure flow studies, in evaluation of BPH and LUTS, 435 Prostate cancer, 5-alpha-reductase inhibitor therapy and, 448 449 association of BPH and, 405 Prostatectomy, laparoscopic and robotic simple, 467 468 open simple, 466 467 outcome compared with holmium laser enucleation of prostate, 493 494 Prostatic enlargement. See Benign prostatic Prostatic hyperplasia. See Benign prostatic Prostatitis, and chronic pelvic pain syndrome, 528 531 Pygeum africanum, 454 455 Q Questionnaires, benign prostatic hyperplasia (BPH) symptoms and outcome measures, 417 429 R Renal failure, progression to, during medical treatment for LUTS, 552 555 young man presenting with, 555 559 Retention, urinary, incidence in aging men, 406 risk for acute, 410 Robotic prostatectomy, simple, 467 468 S Saline bipolar transurethral resection of prostate (TURP), 464 Saw palmetto (Serenoa repens), 454 Serenoa repens, 454 Sexual function, after holmium laser ablation or enucleation of prostate vs. TURP, 493 Silodosin, 446 South African star grass (Hypoxis rooperi), 455 Stents, urethral, for LUTS and BPH, 504 505
Index 575 Surgery, of prostate for LUTS and BPH, 461 470 laparoscopic and robotic simple prostatectomy, 467 468 laser surgery, 471 483, 485 495 open simple prostatectomy, 466 467 transurethral resection of prostate, 461 466 transurethral resection of prostate (TURP), 461 466 current use, 461 efficacy, 463 indications, 461 462 modern technique, 462 463 morbidity and mortality, 463 464 preoperative evaluation, 462 saline, 464 Symptom scores. See Questionnaires. T Tamsulosin, 446 Terazosin, 445 446 Testing. See Urodynamic testing. Tolterodine, 452 453 Transurethral fulguration, of bladder diverticulum, 519, 522 Transurethral microwave thermotherapy (TUMT), 498 500 Transurethral needle aspiration (TUNA), of prostate, 500 502 Transurethral resection of prostate (TURP), 461 466 current use, 461 efficacy, 463 indications, 461 462 modern technique, 462 463 morbidity and mortality, 463 464 outcome compared with holmium laser enucleation of prostate, 491 493 adverse events, 491 492 histology, 491 learning curve, 492 length of operation, 491 sexual function, 493 transurethral resection syndrome, 492 preoperative evaluation, 462 saline, 464 Transurethral resection syndrome, 492 U Urethral stent, for LUTS and BPH, 504 505 Urinary bladder, bladder diverticula, 511 525 decompensated large capacity (case study), 564 567 overactive bladder, case studies, 539 552 painful bladder syndrome, Urinary tract symptoms. See Lower urinary tract symptoms (LUTS). Urodynamic testing, invasive, role in BPH and LUTS, 431 441 videourodynamics, 435 V Vaporization, laser, of prostate in BPH, 471 483, 485 495 Videourodynamics, in evaluation of BPH and LUTS, 435 Voiding diary, 419, 428 429